Please use this identifier to cite or link to this item:
|Title:||Assessment of antihistamine use in early pregnancy and birth defects|
|Citation:||Li, Q., Mitchell, A.A., Werler, M.M., Yau, W.-P., Hernández-Díaz, S. (2013-11). Assessment of antihistamine use in early pregnancy and birth defects. Journal of Allergy and Clinical Immunology: In Practice 1 (6) : 666-674. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jaip.2013.07.008|
|Abstract:||Background: Several studies have reported an association between use of specific antihistamines in early pregnancy and certain specific birth defects. Objective: To test 16 previously hypothesized associations between specific antihistamines and specific birth defects, and to identify possible new associations. Methods: We used 1998-2010 data from the Slone Epidemiology Center Birth Defects Study, a multicenter case-control surveillance program of birth defects in North America. Mothers were interviewed within 6 months of delivery about demographic, reproductive, medical, and behavioral factors, and details on the use of prescription and nonprescription medications. We compared first trimester exposure to specific antihistamines between 13,213 infants with specific malformations and 6982 nonmalformed controls by using conditional logistic regression to estimate odds ratios and 95% confidence intervals (CIs), with adjustment for potential confounders, including indication for use. Results: Overall, 13.7% of controls were exposed to antihistamines during the first trimester. The most commonly used medications were diphenhydramine (4.2%), loratadine (3.1%), doxylamine (1.9%), and chlorpheniramine (1.7%). When estimates were stable, none supported the previously hypothesized associations. Among more than 100 exploratory comparisons of other specific antihistamine-defect pairs, 14 had odds ratios ≥1.5, of which 6 had 95% CI bounds excluding 1.0 before but not after adjustment for multiple comparisons. Conclusion: Our findings do not provide meaningful support for previously posited associations between antihistamines and major congenital anomalies; at the same time, we identified associations that had not been previously suggested. We suspect that previous associations may be chance findings in the context of multiple comparisons, a situation that may also apply to our new findings. © 2013 American Academy of Allergy, Asthma & Immunology.|
|Source Title:||Journal of Allergy and Clinical Immunology: In Practice|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 8, 2018
WEB OF SCIENCETM
checked on Aug 8, 2018
checked on May 4, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.